We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLM:NASDAQSLM Corporation Analysis

Data as of 2026-06-17 - not real-time

$22.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SLM trades at a **trailing P/E of 6.2**, far below the industry average of 17, indicating a substantial valuation gap. The stock price of $22.45 sits just above the computed support of $21.14 and below resistance at $23.31, with the 20‑day SMA (22.08) marginally under the current price, suggesting limited upside in the near term. Technical signals are mixed: the MACD histogram is positive (bullish signal) while the overall trend is flagged as bearish, and the RSI of 52.9 points to a neutral momentum environment. Volume is on an increasing trend, providing decent liquidity despite a 30‑day volatility of 37%, which is high for the sector. Fundamentally, SLM boasts a **gross margin of 100%** and an operating margin of 70%, but operating cash flow is negative and debt‑to‑equity exceeds 250%, highlighting balance‑sheet stress. The company holds over $5.2 bn in cash against $6.2 bn of debt, and its dividend yield of 2.32% is supported by a modest payout ratio of 14%, suggesting current dividend sustainability. Analyst consensus is a “Buy” with a mean target price near $28.8, implying roughly 28% upside. The sector—credit services within financial services—carries medium baseline risk, but regulatory scrutiny of private student loans adds a high overlay. Geographic exposure is concentrated in the United States, limiting currency risk. In this environment, the stock appears **undervalued** with a value‑leaning profile, offering dividend income and potential upside if earnings stabilize.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish trend direction despite bullish MACD
  • Price near technical support with limited upside
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount (P/E 6.2 vs industry 17)
  • Attractive dividend yield with low payout ratio
  • Increasing volume indicating improving market interest

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong profit margins and value‑oriented fundamentals
  • Potential for earnings stabilization as regulatory landscape clarifies
  • Cash reserves sufficient to support dividend and debt service

Key Metrics & Analysis

Financial Health

Revenue Growth2.50%
Profit Margin44.93%
P/E Ratio6.2
ROE30.93%
ROA2.57%
Debt/Equity253.08
P/B Ratio2.0
Op. Cash Flow$-328494016
Industry P/E17.1

Technical Analysis

TrendBearish
RSI52.9
Support$21.14
Resistance$23.31
MA 20$22.08
MA 50$22.25
MA 200$25.08
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Target Price$28.82
Upside/Downside28.37%
GradeUndervalued
TypeValue
Dividend Yield2.32%

Risk Assessment

Beta1.05
Volatility37.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.